Transforming Cancer Drug Development Through Team Science: New Article Documents Journey
The National Cancer Institute’s (NCI’s) Experimental Therapeutics Clinical Trials Network (ETCTN) has transformed the way drugs are developed to fight cancer. A new article in Clinical Cancer Research documents this innovative approach: Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN). The article was coauthored by NCI researchers; Michael Steketee, a Westat Senior Study Director; and others.
Using a “team science” approach, the ETCTN includes 40+ academic institutions, conducting 100+ early-phase clinical trials. The ETCTN promotes collaboration among institutions to further research advances.